Extended Data Figure 4 Effects of binding pocket mutations on potency of NAMs
Brand-name medications have no listed prices
(B) Semaglutide, as a GLP-1 analog, can directly act on fat cells, increase the expression of thermogenic genes for browning phenotype maintenance, improve the expression of uncoupling protein 1 (UCP1), mitochondrial biosynthesis, and thermogenic marker, or promote fatty browning through nitric oxide synthase (NOS), neuropeptides (NPs), sirtuin 1 (STRT1), signal transducer and activator of transcription 3 (STAT3), and bone morphogenetic protein 4 (BMP4) signaling
The good news is that bloating from GLP-1 injections is usually temporary, and most patients find that their symptoms improve as their body adjusts to the medication
This effect of GLP-1s on inflamation is part of why the heart protection appeared larger than weight loss alone could explain
How GLP-1 Microdosing Works Low-dose GLP-1 maintains partial receptor activation enough for insulin sensitivity improvement and mild satiety without causing gastric paralysis or severe nausea